VRTX
Vertex Pharmaceuticals Incorpor · Healthcare · Biotechnology
TECHSellZACKSHold
R500#357 today
$504.73
-0.40% today · -4.08% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- VRTX −0.40% on the last session vs SPY +0.74%: −1.1 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 61 big drops in the past 5 years, VRTX typically gained 0.5% over the next day (median) and was higher 62% of the time; half the outcomes fell between -0.9% and +1.5%. An ordinary day: +0.1%. Among S&P 500 stocks after big drops, that ranks #13 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
VRTX against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #357 | -0.40% | +0.74% | |
| 1 week | #438 | -4.08% | -0.22% | |
| 1 month | #378 | -9.34% | +0.84% | |
| 3 months | #252 | -4.41% | +3.59% | |
| 6 months | #151 | +15.05% | +17.95% | |
| 1 year | #147 | +23.45% | +16.25% | |
| Overall | #312 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Biotechnology
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.14 | #339 | #2 |
| fPE/tPE | 0.85 | #337 | #3 |
| PE/G | 1.97 | #336 | #2 |
| EV/Revenue | 9.70 | #69 | #2 |
| Gross Margin | 0.55 | #177 | #3 |
| Profit Margin | 0.35 | #32 | #1 |
| Revenue Growth | 0.12 | #187 | #3 |